Pierluigi De Santis

Molecular Aberrations Stratify Grade 2 Astrocytomas Into Several Rare Entities: Prognostic and Therapeutic Implications

C. Porta, L. Stucci, M. Tucci, 2022, Frontiers in Oncology.

Prognostic Factors and Current Treatment Strategies for Renal Cell Carcinoma Metastatic to the Brain: An Overview

C. Porta, R. Soffietti, L. Stucci, 2021, Cancers.

The Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer: From Molecular Mechanisms to Clinical Application of New Therapeutic Strategies

P. Fedele, C. Laface, Martina Perrone, 2023, Pharmaceutics.

Immunotherapy in Prostate Cancer: State of Art and New Therapeutic Perspectives

F. Giuliani, P. Fedele, C. Laface, 2023, Current oncology.

Immunotherapy and Pancreatic Cancer: A Lost Challenge?

R. Memeo, P. Fedele, C. Laface, 2023, Life.

The Treatment Landscape of Elderly Patients with Hormone Receptor-Positive Her2 Negative Advanced Breast Cancer: Current Perspectives and Future Directions

C. Laface, A. Melaccio, Martina Perrone, 2023, Journal of clinical medicine.

Antibody–Drug Conjugates in HR+ Breast Cancer: Where Are We Now and Where Are We Heading?

A. Fancellu, V. Sanna, C. Laface, 2023, Journal of clinical medicine.

Early-stage triple negative breast cancer: the therapeutic role of immunotherapy and the prognostic value of pathological complete response

C. Laface, Martina Perrone, Pierluigi De Santis, 2024, Exploration of targeted anti-tumor therapy.